Ketolides belong to a new class of semi-synthetic 14-membered-ring macrolides, which differ from erythromycin A by having a 3-keto group instead of the neutral sugar L-cladinose. The ability of these molecules and their L-cladinose counterparts to induce MLS B resistance in staphylococci (one strain) and streptococci (two strains) was investigated using a disc agar susceptibility method as well as measuring induction kinetics. All 14-and 15-membered ring macrolides tested showed inducing activity. In contrast, ketolides were clearly unable to induce MLS B resistance, a result consistent with the high in-vitro activity of this new class of antibiotics against erythromycin A-inducible resistant bacteria.
Introduction
Macrolides are a well-known family of oral antibiotics. They are used mainly for the treatment of communityacquired respiratory tract infections. However, soon after the introduction of erythromycin A in therapy, resistance appeared in staphylococci, streptococci, pneumococci and enterococci. 1 Furthermore, there is full cross-resistance among all available macrolides, lincosamides and group B steptogramins, giving rise to the so-called phenotype of MLS B resistance.
MLS B resistance is due to target site modification by a family of enzymes which mono-or di-methylate the N 6 amino group of adenine residue 2058 in 23S rRNA, thus preventing access of the antibiotic to its binding site on the ribosome. 2 The observed cross-resistance to the three structurally unrelated groups of antibiotics is explained by their known overlapping binding site in 50S ribosomal subunits. 3 In staphylococci, MLS B resistance can be constitutively expressed. More frequently, it can be induced in the presence of 14-and 15-, but not 16-membered-ring macrolides. 4, 5 In contrast, 16-membered-ring macrolides are also able to induce the MLS B phenotype of resistance in the Streptococcus genus. 2 Ketolides are a new class of semi-synthetic 14-membered-ring macrolides, characterized by a 3-keto function in place of the L-cladinose moiety, a neutral sugar long thought to be essential for antibacterial activity. Among them, RU 64004 was found to be very active against respiratory pathogens, particularly pneumococci, irrespective of their phenotype of resistance. 6 Here we compare RU 64004 and other ketolides with their macrolide analogues in their ability to induce MLS B resistance.
Materials and methods

Bacterial strains
Three erythromycin A-inducible resistant strains were tested: Staphylococcus aureus 011Go25, Streptococcus pyogenes 02A1Fi12 and Streptococcus pneumoniae 030Bi2.
Antibiotics
All compounds were synthesized at Roussel Uclaf (Romainville, France) except rokitamycin, a 16-membered-ring macrolide (Toyo-Jozo, Shizuoka, Japan). The following pairs of ketolide/macrolide analogues were studied: RU 64004 and RU 66252; RU 56006 and clarithromycin; RU 59616 and azithromycin. Rokitamycin and erythromycin A were used as control antibiotics.
Determination of MICs
MICs were determined using a microdilution method in Brain Heart Infusion (Sanofi Diagnostics Pasteur (SDP), Marnes, France). In the case of S. pneumoniae, this medium was supplemented with 4% globular extract (SDP), containing growth factors X and V. Reading was performed after 24 h incubation in ambient atmosphere at 37°C. culture was prepared by adding 0.5 mL of an overnight bacterial culture to 4.5 mL of Brain Heart Infusion, containing an inducing subinhibitory concentration of the compound studied. In the case of S. pneumoniae, 4% of globular extract was added in the broth. When the optical density (OD) of the culture at 580 nm reached 0.3-0.5 units, a challenge inhibitory dose of the test drug (50 mg/L final) was added to the induced and the non-induced bacterial cultures (controls). OD were then recorded for 7-9 h. Subinhibitory concentrations used for induction were adapted from the work of Hyder & Streitfeld, 7 depending on strains and drugs. With S. aureus and S. pyogenes, doses of erythromycin A, clarithromycin and azithromycin were 0.06 mg/L while the dose of RU compounds was 0.006 mg/L. Doses were ten-fold lower in the case of S. pneumoniae.
Disc agar susceptibility test
Each strain was grown for 24 h on Mueller-Hinton agar (SDP) or supplemented with 7% horse blood (SDP) for staphylococci and streptococci, respectively. Antagonistic interactions between macrolides and ketolides were studied using drug-impregnated home-made discs (15 g/disc), placed close to each other before incubation. The D-shaped inhibition zone around a disc demonstrated induction of resistance by the antibiotic on the neighbouring disc. 
Results
In-vitro activity of ketolides and their macrolide analogues
Induced resistance tested by susceptibility discs
Patterns of induced resistance in agar medium, plated with S. aureus 011Go25, are shown in Figure 2 . Erythromycin A, azithromycin and clarithromycin exhibited very strong inducing activities, as shown by the distorted D-shaped inhibition zones between them and rokitamycin. Ketolide derivatives, including RU 64004, did not induce resistance. Furthermore, erythromycin A clearly induced resistance to RU 64004. Each strain, whatever the bacterial genus or species, displayed similar behaviour (data not shown).
Kinetics of induction in broth
Induction of resistance to erythromycin A or to each compound itself was tested against the three bacterial strains. Figure 3a shows that prior incubation with subinhibitory concentrations of erythromycin A, clarithromycin and azithromycin was required before S. aureus 011Go25 exhibited higher growth than that of the control after addition of a challenge inhibitory dose of erythromycin A. In other words, these macrolides were strong inducers of macrolide resistance. In contrast, subinhibitory concentrations of RU 56006 and RU 59616, the 3-keto analogues of clarithromycin and azithromycin, did not alter bacterial growth in comparison with the control. This demonstrated absence of inductive potential for both compounds. In the same way, no induction was obtained with RU 64004, in contrast to its cladinose analogue, RU 66252 (Figure 3b) . Kinetics of induction determined with S. pneumoniae 030Bi2 and S. pyogenes 02A1Fi12 were similar to that obtained with staphylococcus (Figures 4 and 5) .
Discussion
MLS B resistance in Gram-positive cocci can be constitutively or inducibly expressed. While only 14-and 15-membered ring macrolides are inducers of resistance in S. aureus, various macrolides can induce the MLS B phenotype in streptococci and pneumococci. 2, 8 It has previously been suggested that the inductive potential of 14-and 15-membered-ring macrolides may be partly due to the L-cladinose moiety, a neutral sugar attached to the C-3 position of the lactone ring. 9 The presence of L-cladinose could make a distinct conformation of the macrolactone, explaining the inducing behaviour of the 14-and 15-membered-ring macrolides. Here, we show that erythromycin A, azithromycin, clarithromycin and RU 66252, which all possess a Lcladinose in position 3, are strong inducers of MLS B resistance in various erythromycin A-inducible resistant strains. In contrast, the counterpart ketolide derivatives and rokitamycin are unable to induce resistance to erythromycin A, as demonstrated by the disc test and by the kinetics of induction. As already mentioned, in streptococci, numerous macrolides, lincosamides and streptogramins B can serve as potential inducers. In such strains, to prevent the non-detection of resistance induction, 10 we used kinetics in broth media in combination with the susceptibility disc method.
As already reported, RU 64004 displays good antibacterial activity against erythromycin A-inducible resistant Gram-positive cocci. It is worth noting that these strains are susceptible at a level identical or close to that found with susceptible bacteria. 11 We can infer from these results that, unlike macrolides, ketolides are non-inducers of MLS B resistance, at least in staphylococci and streptococci.
We focused on alterations of the phenotype, not on the genotype, in the strains tested here. Gene regulation experiments are now ongoing, in order to look in more detail at why ketolides appear as non-inducers. Moreover, the use of ketolides will allow elucidation of the role of sugar residues in the precise mode of action of a macrolide drug. 
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